HK1079771A1 - Process for the manufacture of valsartan - Google Patents

Process for the manufacture of valsartan

Info

Publication number
HK1079771A1
HK1079771A1 HK05111768A HK05111768A HK1079771A1 HK 1079771 A1 HK1079771 A1 HK 1079771A1 HK 05111768 A HK05111768 A HK 05111768A HK 05111768 A HK05111768 A HK 05111768A HK 1079771 A1 HK1079771 A1 HK 1079771A1
Authority
HK
Hong Kong
Prior art keywords
valsartan
manufacture
Prior art date
Application number
HK05111768A
Other languages
English (en)
Inventor
Denni-Dischert Donatienne
Hirt Hans
Neville Dan
Sedelmeier Gottfried
Schnyder Anita
Derrien Nadine
Kaufmann Daniel
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9944606&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1079771(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1079771A1 publication Critical patent/HK1079771A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
HK05111768A 2002-09-23 2005-12-20 Process for the manufacture of valsartan HK1079771A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0222056.4A GB0222056D0 (en) 2002-09-23 2002-09-23 Process for the manufacture of organic compounds
PCT/EP2003/010543 WO2004026847A1 (en) 2002-09-23 2003-09-22 Process for the manufacture of valsartan

Publications (1)

Publication Number Publication Date
HK1079771A1 true HK1079771A1 (en) 2006-04-13

Family

ID=9944606

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05111768A HK1079771A1 (en) 2002-09-23 2005-12-20 Process for the manufacture of valsartan

Country Status (30)

Country Link
US (3) US20060069268A1 (xx)
EP (2) EP1878729A1 (xx)
JP (2) JP4787498B2 (xx)
KR (2) KR20050057529A (xx)
CN (2) CN100357279C (xx)
AR (1) AR041360A1 (xx)
AU (1) AU2003270241B2 (xx)
BR (1) BR0314132A (xx)
CA (1) CA2502629A1 (xx)
CY (1) CY1107878T1 (xx)
DE (1) DE60317690T2 (xx)
DK (1) DK1546122T3 (xx)
EC (2) ECSP055695A (xx)
ES (1) ES2295623T3 (xx)
GB (1) GB0222056D0 (xx)
HK (1) HK1079771A1 (xx)
IL (1) IL167426A (xx)
MX (1) MXPA05003140A (xx)
MY (1) MY138618A (xx)
NO (2) NO20051970L (xx)
NZ (2) NZ566863A (xx)
PE (2) PE20091387A1 (xx)
PL (1) PL374862A1 (xx)
PT (1) PT1546122E (xx)
RU (2) RU2348619C2 (xx)
SG (1) SG155049A1 (xx)
SI (1) SI1546122T1 (xx)
TW (2) TWI329106B (xx)
WO (1) WO2004026847A1 (xx)
ZA (1) ZA200502159B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1511739B1 (en) * 2003-03-17 2008-04-30 Teva Pharmaceutical Industries Ltd. Polymorphs of valsartan
US7199144B2 (en) 2003-04-21 2007-04-03 Teva Pharmaceuticals Industries, Ltd. Process for the preparation of valsartan and intermediates thereof
EP1556363A2 (en) * 2003-04-21 2005-07-27 Teva Pharmaceutical Industries Limited Process for the preparation of valsartan and intermediates thereof
US7378531B2 (en) 2003-04-21 2008-05-27 Teva Pharmaceutical Industries Ltd Process for the preparation of valsartan
GB0316546D0 (en) 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
GB0402262D0 (en) * 2004-02-02 2004-03-10 Novartis Ag Process for the manufacture of organic compounds
EP1661891A1 (en) * 2004-11-30 2006-05-31 KRKA, D.D., Novo Mesto A process for the synthesis of valsartan
GB0514206D0 (en) 2005-07-11 2005-08-17 Novartis Ag Organic compounds
ES2288376B1 (es) * 2005-10-20 2008-11-01 Inke, S.A. Procedimiento para la obtencion de intermedios utiles en la obtencion de un compuesto farmaceuticamente activo.
WO2007057919A2 (en) * 2005-10-25 2007-05-24 Alembic Limited An improved process for preparation of (s)-n-(1-carboxy-2-methyl-prop-1-yl)-n-pentanoyl-n-[2'-(1h-tetrazol-5-yl)biphenyl-4-ylmethyl]-amine
EP2057132A2 (en) * 2006-07-03 2009-05-13 Aurobindo Pharma Limited Process for the preparation of the angiotensin ii antagonist valsartan
ES2315141B1 (es) * 2006-11-23 2009-12-22 Quimica Sintetica, S.A Procedimiento para la preparacion de cardesartan cilexetilo en forma cristalina.
CN101200455B (zh) * 2007-09-29 2010-08-18 泰兴市江神化工有限公司 沙坦类治疗高血压药物主环5-(4'-甲酰基联苯-2-基)-1h-四氮唑的制备方法
US7943794B2 (en) * 2008-02-13 2011-05-17 Ranbaxy Laboratories Limited Processes for the preparation of intermediates of valsartan
KR101012135B1 (ko) * 2008-12-18 2011-02-07 주식회사 대희화학 발사르탄 메틸 에스테르의 제조방법
EP2316821A1 (en) 2009-10-27 2011-05-04 Novartis AG Process for the manufacture of organic compounds
CA2806657A1 (en) * 2010-08-03 2012-02-09 Novartis Ag Highly crystalline valsartan
CN102351804B (zh) * 2011-09-30 2013-07-31 浙江新赛科药业有限公司 一种缬沙坦消旋体的回收方法
CN103554047A (zh) * 2013-10-11 2014-02-05 镇江市高等专科学校 制备缬沙坦的方法
CN103923028B (zh) * 2014-05-04 2017-05-24 青岛雪洁助剂有限公司 一种缬沙坦甲酯的制备方法
CN104072433A (zh) * 2014-07-16 2014-10-01 南京正大天晴制药有限公司 一种缬沙坦的水解杂质化合物及其制备方法、检测方法和用途
CN104151199A (zh) * 2014-08-13 2014-11-19 苏州卫生职业技术学院 一种缬沙坦的合成方法
CN104844476B (zh) * 2015-04-03 2016-08-24 李凌 一种医药中间体联苯类化合物的合成方法
CN112014479A (zh) * 2019-05-28 2020-12-01 珠海润都制药股份有限公司 一种缬沙坦中正戊酰氯的检测方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0443983B1 (de) * 1990-02-19 1996-02-28 Ciba-Geigy Ag Acylverbindungen
US5260325A (en) * 1991-08-19 1993-11-09 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking tertiary amides
EP0550313A1 (fr) * 1991-12-30 1993-07-07 Synthelabo Nouveaux dérivés de 2-(tétrazol-5-yl)-(1,1'-biphényle), leur préparation et leur utilisation comme intermédiaires de synthèse
FR2688503B1 (fr) * 1992-03-16 1994-05-06 Synthelabo Procede de preparation de derives de 2-(tetrazol-5-yl)-[1,1'-biphenyle].
US5284957A (en) * 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
JPH08165292A (ja) * 1993-10-07 1996-06-25 Techno Res Kk アデニン誘導体、その製造法及び用途
US5468867A (en) * 1994-05-27 1995-11-21 Syntex (U.S.A.) Inc. Process for preparing1-butyl-2-[2'-(2H-tetrazol-5-yl)biphenyl-4-ylmethyl1-1H-indole-3-carboxylic acid
US5412102A (en) * 1994-05-27 1995-05-02 Syntex (U.S.A.) Inc. Processes for preparing 1-butyl-2-[2'-(2H-tetrazol-5-yl) biphenyl-4-ylmethyl]-1H-indole-3-carboxylic acid
WO1996009301A1 (fr) * 1994-09-20 1996-03-28 Wakunaga Seiyaku Kabushiki Kaisha Procede de production d'un derive de n-biphenylmethylthiadiazoline ou un sel de celui-ci et son intermediaire de production
BR9609403A (pt) * 1995-06-07 1999-05-11 American Home Prod Processo para a preparação de derivados de bifenila
CN1137887C (zh) * 2000-04-07 2004-02-11 常州四药制药有限公司 一种合成缬沙坦的改进方法
CN1216873C (zh) * 2000-07-19 2005-08-31 诺瓦提斯公司 缬沙坦的盐
GB0402262D0 (en) * 2004-02-02 2004-03-10 Novartis Ag Process for the manufacture of organic compounds

Also Published As

Publication number Publication date
US20100249429A1 (en) 2010-09-30
NZ566863A (en) 2009-08-28
EP1546122B8 (en) 2008-05-28
EP1546122A1 (en) 2005-06-29
IL167426A (en) 2010-11-30
JP2010254709A (ja) 2010-11-11
CN101153027A (zh) 2008-04-02
CY1107878T1 (el) 2013-06-19
TWI338003B (en) 2011-03-01
NO20051970L (no) 2005-06-16
ZA200502159B (en) 2005-09-21
EP1546122B1 (en) 2007-11-21
PE20091387A1 (es) 2009-10-13
PL374862A1 (en) 2005-11-14
RU2005112444A (ru) 2006-01-20
RU2412173C2 (ru) 2011-02-20
DE60317690T2 (de) 2008-10-30
SG155049A1 (en) 2009-09-30
JP2006502178A (ja) 2006-01-19
DE60317690D1 (de) 2008-01-03
PT1546122E (pt) 2008-02-14
NO20110856L (no) 2005-06-16
KR20050057529A (ko) 2005-06-16
MXPA05003140A (es) 2005-06-22
CN101153027B (zh) 2010-08-18
ES2295623T3 (es) 2008-04-16
TW201016673A (en) 2010-05-01
AU2003270241A1 (en) 2004-04-08
JP4787498B2 (ja) 2011-10-05
US20060069268A1 (en) 2006-03-30
RU2008133680A (ru) 2010-02-27
DK1546122T3 (da) 2008-03-03
ECSP055695A (es) 2005-05-30
KR20110015703A (ko) 2011-02-16
TW200413337A (en) 2004-08-01
TWI329106B (en) 2010-08-21
PE20050088A1 (es) 2005-02-21
WO2004026847A1 (en) 2004-04-01
RU2348619C2 (ru) 2009-03-10
BR0314132A (pt) 2005-06-28
NZ538927A (en) 2008-05-30
ECSP105695A (es) 2010-03-31
CN1688556A (zh) 2005-10-26
US20090111995A1 (en) 2009-04-30
AU2003270241B2 (en) 2007-08-23
AR041360A1 (es) 2005-05-11
EP1878729A1 (en) 2008-01-16
CA2502629A1 (en) 2004-04-01
MY138618A (en) 2009-07-31
SI1546122T1 (sl) 2008-04-30
GB0222056D0 (en) 2002-10-30
CN100357279C (zh) 2007-12-26

Similar Documents

Publication Publication Date Title
HK1079771A1 (en) Process for the manufacture of valsartan
IL173456A0 (en) Process for the preparation of 4-amino-3-quinolinecarbonitriles
ZA200405256B (en) Process for the production of hydrocarbons
SI2322511T1 (sl) Postopek za pripravo telmisartana
ZA200405239B (en) Process for the manufacture of organic compounds
GB0204129D0 (en) Process for the manufacture of organic compounds
IL175743A0 (en) Process for the preparation of thiazolopyrimidines
GB0210234D0 (en) Process for the manufacture of organic compounds
PL377943A1 (pl) Sposób wytwarzania benzofenonów
SI1403264T1 (en) Process for the industrial synthesis of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxydimethylester
HUP0600231A2 (en) Novel process for the preparation of 2h-chromenes
GB0216311D0 (en) An improved process for the production of substituted thioxanthones
IL165137A0 (en) Process for the preparation of thioalkylamine derivatives
AU2002367890A1 (en) Process for the preparation of 4-methyl-thiazole-5-carbaldehyde intermediate
MY136695A (en) Process for the preparation of alkylaryl compounds
HK1095145A1 (en) Process for the preparation of n-arylmorpholinones n-
PL371583A1 (en) Process for the preparation of 7alpha-methylsteroids
SG111997A1 (en) Improved process for the preparation of polyalkylphenoxyaminoalkanes
IL164788A0 (en) Process for the preparation of 3-isochromanone
EG24122A (en) Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolines
EP1539772A4 (en) PROCESS FOR PREPARING PHOSPHORDIAMIDITE COMPOUNDS
IL161897A0 (en) Process for the preparation of cephalexin
HK1087111A1 (en) Process for the preparation of nicotinaldehydes
IL174980A0 (en) Process for the preparation of a trifluoromethylthioether
EP1386911A3 (de) Verfahren zur Herstellung von Acyloxybenzolsulfonaten

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120922